CALQUENCE acalabrutinib 100 mg capsule blister pack

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3acda7afe6e51d24
Product Name: CALQUENCE acalabrutinib 100 mg capsule blister pack
Artg Id: 321419
Artg Name: CALQUENCE acalabrutinib 100 mg capsule blister pack
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2019-11-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REPI
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/5feca688b4aa077d0b429c1e2aa46c03.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c49bf7dbb17b29856a9044b6efc1c0d1.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3acda7afe6e51d24

Type

Standard